ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and …

Ž Reiner, AL Catapano, G De Backer… - European heart …, 2011 - academic.oup.com
Surveys and registries are needed to verify that real-life daily practice is in keeping with what
is recommended in the guidelines, thus completing the loop between clinical research …

2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular …

Authors/Task Force Members… - European heart …, 2014 - academic.oup.com
Surveys and registries are needed to verify that real-life daily practice is in keeping with what
is recommended in the guidelines, thus completing the loop between clinical research …

Vitamin K antagonists in heart disease: Current status and perspectives (Section III)

R De Caterina, S Husted, L Wallentin… - Thrombosis and …, 2013 - thieme-connect.com
Oral anticoagulants are a mainstay of cardiovascular therapy, and for over 60 years vitamin
K antagonists (VKAs) were the only available agents for long-term use. VKAs interfere with …

ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force on the management of ST …

Authors/Task Force Members, PG Steg… - European heart …, 2012 - academic.oup.com
The task of developing ESC Guidelines covers not only the integration of the most recent
research, but also the creation of educational tools and implementation programmes for the …

ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the …

Authors/Task Force Members, CW Hamm… - European heart …, 2011 - academic.oup.com
ESC Guidelines 3002 recommendations. To implement the guidelines, condensed pocket
guidelines versions, summary slides, booklets with essential messages, and an electronic …

Guidelines on myocardial revascularization: the task force on myocardial revascularization of the European Society of Cardiology (ESC) and the European …

Developed with the Special Contribution of … - European heart …, 2010 - academic.oup.com
Some surveys have shown that the intended users are sometimes unaware of the existence
of guidelines, or simply do not translate them into practice. Thus, implementation …

Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation …

Authors/Task Force Members… - European heart …, 2008 - academic.oup.com
Document Reviewers: Sigmund Silber (CPG Review Coordinator)(Germany), Frank V.
Aguirre (USA), Nawwar Al-Attar (France), Eduardo Alegria (Spain), Felicita Andreotti (Italy) …

Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: The Task Force for the Diagnosis and Treatment of Non-ST …

JP Bassand, CW Hamm, D Ardissino… - European heart …, 2007 - academic.oup.com
The content of these European Society of Cardiology (ESC) Guidelines has been published
for personal and educational use only. No commercial use is authorized. No part of the ESC …

Guidelines on the management of stable angina pectoris: executive summary: the Task Force on the Management of Stable Angina Pectoris of the European Society …

Authors/Task Force Members, K Fox… - European heart …, 2006 - academic.oup.com
Stable angina pectoris is a common and sometimes disabling disorder. The development of
new tools for the diagnostic and prognostic assessments of patients, along with the …

Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of …

JW Eikelboom, L Wallentin, SJ Connolly, M Ezekowitz… - Circulation, 2011 - Am Heart Assoc
Background—Dabigatran 150 and 110 mg twice a day and warfarin are effective for stroke
prevention in atrial fibrillation. The purpose of this study was to compare their risks of …